Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12865)
All Articles published online
|
Publishing Process of This Article
|
Feb 18, 2017 (publication date) through Nov 5, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kayaaslan B, Guner R. Adverse effects of oral antiviral therapy in chronic hepatitis B. World J Hepatol 2017; 9(5): 227-241 [PMID: 28261380 DOI: 10.4254/wjh.v9.i5.227] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v9/i5/227.htm |
| Number | Citing Articles |
| 1 |
Chun-Ru Cheng, Uwem O. Edet, Innocent Benjamin, Chinyere U. Okoro, Wilfred Emori, Elizabeth N. Mbim, Obinna C. Godfrey, Francisca O. Nwaokorie, Jenavine O. Mbah, Richard U. Ukpanukpong, Amanda-Lee E. Manicum, Hitler Louis. Effect of solvation on the molecular structure, vibrational assignment, nature of bonding, and the antiviral drug-like potential of troxerutin against HBV proteins. Journal of the Indian Chemical Society 2023; 100(6): 100994 doi: 10.1016/j.jics.2023.100994
|
| 2 |
Raquel Scherer de Fraga, Victor Van Vaisberg, Luiz Cláudio Alfaia Mendes, Flair José Carrilho, Suzane Kioko Ono. Adverse events of nucleos(t)ide analogues for chronic hepatitis B: a systematic review. Journal of Gastroenterology 2020; 55(5): 496 doi: 10.1007/s00535-020-01680-0
|
| 3 |
Monisha Simon, Ameena Meah. Tenofovir as a Cause of Acquired Fanconi's Syndrome. Annals of African Medicine 2023; 22(1): 128 doi: 10.4103/aam.aam_198_21
|
| 4 |
Lukasz T. Olenginski, Solomon K. Attionu, Erica N. Henninger, Regan M. LeBlanc, Andrew P. Longhini, Theodore K. Dayie. Hepatitis B Virus Epsilon (ε) RNA Element: Dynamic Regulator of Viral Replication and Attractive Therapeutic Target. Viruses 2023; 15(9): 1913 doi: 10.3390/v15091913
|
| 5 |
Mojisola Ogunnaike, Srijanee Das, Samiksha S. Raut, Ashrafi Sultana, Mohammad Ullah Nayan, Murali Ganesan, Benson J. Edagwa, Natalia A. Osna, Larisa Y. Poluektova. Chronic Hepatitis B Infection: New Approaches towards Cure. Biomolecules 2023; 13(8): 1208 doi: 10.3390/biom13081208
|
| 6 |
Pragyan Kumar Routray, Pragati Jena, Debasis Mishra. Principles and Practice of Neurocritical Care. 2024; : 277 doi: 10.1007/978-981-99-8059-8_19
|
| 7 |
Bijayata Patra, Poulomi Ghosh, Saprativ P. Das. Model Organisms to Study Biological Activities and Toxicity of Nanoparticles. 2020; : 195 doi: 10.1007/978-981-15-1702-0_10
|
| 8 |
William W. L. Wong, Petros Pechivanoglou, Josephine Wong, Joanna M. Bielecki, Alex Haines, Aysegul Erman, Yasmin Saeed, Arcturus Phoon, Mina Tadrous, Mona Younis, Noha Z. Rayad, Valeria Rac, Harry L. A. Janssen, Murray D. Krahn. Antiviral treatment for treatment-naïve chronic hepatitis B: systematic review and network meta-analysis of randomized controlled trials. Systematic Reviews 2019; 8(1) doi: 10.1186/s13643-019-1126-1
|
| 9 |
Yutaka Tsukune, Makoto Sasaki, Norio Komatsu. Reactivation of Hepatitis B Virus in Patients with Multiple Myeloma. Cancers 2019; 11(11): 1819 doi: 10.3390/cancers11111819
|
| 10 |
Luca Soraci, Antonio Cherubini, Luca Paoletti, Gianfranco Filippelli, Filippo Luciani, Pasqualina Laganà, Maria Elsa Gambuzza, Elvira Filicetti, Andrea Corsonello, Fabrizia Lattanzio. Safety and Tolerability of Antimicrobial Agents in the Older Patient. Drugs & Aging 2023; 40(6): 499 doi: 10.1007/s40266-023-01019-3
|
| 11 |
Heejoon Jang, Su Jong Yu, Hong Ghi Lee, Tae Min Kim, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Jung-Hwan Yoon, Yoon Jun Kim. Efficacy of Antiviral Prophylaxis up to 6 or 12 Months From Completion of Rituximab in Resolved Hepatitis B Patients: A Multicenter, Randomized Study. Journal of Korean Medical Science 2023; 38(28) doi: 10.3346/jkms.2023.38.e216
|
| 12 |
Takayuki Fujii, Kei‐ichiro Takase, Hiroyuki Honda, Nobutoshi Kawamura, Ryo Yamasaki, Michiyo Urata, Takeshi Uchiumi, Toru Iwaki, Jun‐ichi Kira. Toxic myopathy with multiple deletions in mitochondrial DNA associated with long‐term use of oral anti‐viral drugs for hepatitis B: A case study. Neuropathology 2019; 39(2): 162 doi: 10.1111/neup.12548
|
| 13 |
Alessandra M. de A. Maciel, Maria Lucia C. G. Ferraz, Renata de M. Perez, Carlos Eduardo Brandão-Mello. Renal dysfunction during treatment of chronic hepatitis B with tenofovir disoproxyl fumarate and associated risk factors. European Journal of Gastroenterology & Hepatology 2024; 36(4): 482 doi: 10.1097/MEG.0000000000002723
|
| 14 |
Su‐Shen Lim, Hsien‐Tzung Liao, Chang‐Youh Tsai. Telbivudine associated mitochondrial myopathy. Liver International 2018; 38(6): 1139 doi: 10.1111/liv.13742
|
| 15 |
Soon Sun Kim, Eun Kyoung Ahn, Soo Yeon Cho, Rae Woong Park, Hyo Jung Cho, Ji-Hyun Kim, Han Gyeol Kim, Ga Ram Lee, Sun Hyuk Hwang, Min Jae Yang, Jae Youn Cheong, Sung Won Cho. Impact of nucleos(t)ide analog treatment on the development of malignancy in patients with chronic hepatitis B. Medicine 2018; 97(24): e11087 doi: 10.1097/MD.0000000000011087
|
| 16 |
Vishal S. Patil, Darasaguppe R. Harish, Umashankar Vetrivel, Sanjay H. Deshpande, Pukar Khanal, Harsha V. Hegde, Subarna Roy, Sunil S. Jalalpure. Pharmacoinformatics Analysis Reveals Flavonoids and Diterpenoids from Andrographis paniculata and Thespesia populnea to Target Hepatocellular Carcinoma Induced by Hepatitis B Virus. Applied Sciences 2022; 12(21): 10691 doi: 10.3390/app122110691
|
| 17 |
Nese Inan, Fehmi Tabak. Viral Hepatitis: Chronic Hepatitis B. 2018; : 71 doi: 10.1007/978-3-319-93449-5_7
|
| 18 |
Nikki Ledoux. Hepatitis B and Acute Liver Failure. Critical Care Nursing Clinics of North America 2022; 34(3): 259 doi: 10.1016/j.cnc.2022.04.012
|
| 19 |
I. Vern Lim, Nurgül Özgür Yurttaş, Mesut Ayer, Şule Poturoğlu, Erdem Kınacı, İlgin Özden. Entecavir‐induced neutropenia in an adult living donor liver transplant recipient: Successful conversion to tenofovir alafenamide. Clinical Case Reports 2023; 11(8) doi: 10.1002/ccr3.7741
|
| 20 |
玉娇 常. Progress of Research on the Current Status and Influencing Factors of Medication Adherence in Chronic Hepatitis B Patients. Advances in Clinical Medicine 2024; 14(05): 787 doi: 10.12677/acm.2024.1451492
|
| 21 |
Sreekumar Othumpangat, John D. Noti. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. Side Effects of Drugs Annual 2018; 40: 345 doi: 10.1016/bs.seda.2018.08.005
|
| 22 |
Nicholas Zareifopoulos, Maria Lagadinou, Anastasia Karela, Ourania Kyriakopoulou, Dimitrios Velissaris. Neuropsychiatric Effects of Antiviral Drugs. Cureus 2020; doi: 10.7759/cureus.9536
|
| 23 |
In Suk Min, Chang Hun Lee, Ik Sang Shin, Na Eun Lee, Hong Seon Son, Seung Bum Kim, Seung Young Seo, Seong Hun Kim, Sang Wook Kim, Seung Ok Lee, Soo Teik Lee, In Hee Kim. Treatment Outcome and Renal Safety of 3-Year Tenofovir Disoproxil Fumarate Therapy in Chronic Hepatitis B Patients with Preserved Glomerular Filtration Rate. Gut and Liver 2019; 13(1): 93 doi: 10.5009/gnl18183
|
| 24 |
Beyza Dönmüş, Sinan Ünal, Fatma Ceren Kirmizitaş, Nelisa Türkoğlu Laçin. Virus-associated ribozymes and nano carriers against COVID-19. Artificial Cells, Nanomedicine, and Biotechnology 2021; 49(1): 204 doi: 10.1080/21691401.2021.1890103
|
| 25 |
Xiao Lin, Aixin Song, Sujun Zheng, Xinyue Chen. Respiratory failure as the prominent manifestation of entecavir-associated mitochondrial myopathy: a case report. BMC Infectious Diseases 2022; 22(1) doi: 10.1186/s12879-022-07159-y
|
| 26 |
Robério Amorim de Almeida Pondé, Guilherme de Sousa Pondé Amorim. Elimination of the hepatitis B virus: A goal, a challenge. Medicinal Research Reviews 2024; 44(5): 2015 doi: 10.1002/med.22030
|
| 27 |
Suman Pilli, Peck Lin Lip. Reversible retinal toxicity in early oral Entecavir therapy for hepatitis-B infection. Eye 2018; 32(11): 1792 doi: 10.1038/s41433-018-0156-6
|
| 28 |
Yiqi Yu, Jingwen Ai, Wenhong Zhang. Current clinical evidence for nucleos(t)ide analogues in patients with HBV-related hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2017; 11(10): 925 doi: 10.1080/17474124.2017.1343665
|
| 29 |
Burcu ÖNDER, Fatih Oğuz ÖNDER, Betül YAVUZ KELEŞ. Antiviral Use-Related Femoral Neuropathy: A Case Report Femoral Neuropathy. Acibadem Universitesi Saglik Bilimleri Dergisi 2020; 12(1): 156 doi: 10.31067/acusaglik.831303
|
| 30 |
Zhouqi Tang, Tengfang Li, Helong Dai, Chen Feng, Xubiao Xie, Fenghua Peng, Gongbin Lan, Shaojie Yu, Yu Wang, Chunhua Fang, Manhua Nie, Xiaoqiong Yuan, Xiaotian Tang, Xin Jiang, Xuejing Zhu, Yuxi Fan, Jiawei Peng, Siyu Sun, Mingda Zhong, Hedong Zhang, Longkai Peng. Drug-induced Fanconi syndrome in patients with kidney allograft transplantation. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.979983
|
| 31 |
Rob Bielen, Geert Robaeys, Sigrid Schelfhout, Diethard Monbaliu, Schalk Van der Merwe, Jacques Pirenne, Frederik Nevens. Personalized subcutaneous administration of hepatitis B surface antibodies without nucleos(t)ide analogs for patients at risk of renal failure after liver transplantation: a prospective single center cohort study. Transplant International 2018; 31(5): 503 doi: 10.1111/tri.13112
|
| 32 |
Jirayu Kammarabutr, Panupong Mahalapbutr, Hisashi Okumura, Peter Wolschann, Thanyada Rungrotmongkol. Structural dynamics and susceptibility of anti-HIV drugs against HBV reverse transcriptase. Journal of Biomolecular Structure and Dynamics 2021; 39(7): 2502 doi: 10.1080/07391102.2020.1751715
|
| 33 |
Shankar Ganesh M, Asifsha D, Venkateswaramurthy N. Potential Drug-Drug Interactions with Adefovir Dipivoxil: Clinical Implications and Management Strategies. Biosciences Biotechnology Research Asia 2024; 21(2): 509 doi: 10.13005/bbra/3243
|
| 34 |
Meng Zhu, Lingjuan Jia, Yike Wang, Yongsheng Zhang, Shengxia Lv. Comparative evaluation of adverse drug reactions for tenofovir alafenamide and tenofovir disoproxil fumarate using the FAERS Database: a disproportionality analysis. Expert Opinion on Drug Safety 2024; : 1 doi: 10.1080/14740338.2024.2391496
|
| 35 |
Jihye Lim, Jung‐Bok Lee, Jihyun An, Gi‐Won Song, Kang Mo Kim, Han Chu Lee, Ju Hyun Shim. Extrahepatic carcinogenicity of oral nucleos(t)ide analogues in chronic hepatitis B carriers: A 35,000‐Korean outcome study. Journal of Viral Hepatitis 2022; 29(9): 756 doi: 10.1111/jvh.13721
|
| 36 |
Mei-Juan Peng, Xiao-Qing Guo, Wei-Lu Zhang, Jing Chen, Wen Kang, Xiao-Fei Yang, Ying Guo, Ye Zhang. Effect of pegylated interferon-α2b add-on therapy on renal function in chronic hepatitis B patients: A real-world experience. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.980250
|
| 37 |
Di Liu, Lin Liu, Lizheng Wang, Sizhu Duan, Yanan Song, Meng Qu, Nan Gao, Jiaxin Wu, Haihong Zhang, Hui Wu, Wei Kong, Bin Yu, Xianghui Yu. Therapeutic effects of mesenchymal stem cells combined with short hairpin RNA on liver injury induced by hepatitis B virus infection. Molecular Medicine Reports 2017; doi: 10.3892/mmr.2017.8096
|
| 38 |
Mariam Nasser Aljaafari, Asma Obaid AlAli, Laila Baqais, Maream Alqubaisy, Mudhi AlAli, Aidin Molouki, Janna Ong-Abdullah, Aisha Abushelaibi, Kok-Song Lai, Swee-Hua Erin Lim. An Overview of the Potential Therapeutic Applications of Essential Oils. Molecules 2021; 26(3): 628 doi: 10.3390/molecules26030628
|
| 39 |
Ana Isabel Ribeiro, Alice Maria Dias, Andrea Zille. Synergistic Effects Between Metal Nanoparticles and Commercial Antimicrobial Agents: A Review. ACS Applied Nano Materials 2022; 5(3): 3030 doi: 10.1021/acsanm.1c03891
|
| 40 |
Lukas Cerveny, Sara Karbanova, Rona Karahoda, Hana Horackova, Lucie Jiraskova, Mohammed Naji Husaen Ali, Frantisek Staud. Assessment of the role of nucleoside transporters, P-glycoprotein, breast cancer resistance protein, and multidrug resistance-associated protein 2 in the placental transport of entecavir using in vitro, ex vivo, and in situ methods. Toxicology and Applied Pharmacology 2023; 463: 116427 doi: 10.1016/j.taap.2023.116427
|
| 41 |
Kerui Xu, Li-Ming Liu, Paraskevi A. Farazi, Hongmei Wang, Fedja A Rochling, Shinobu Watanabe-Galloway, Jian-Jun Zhang. Adherence and perceived barriers to oral antiviral therapy for chronic hepatitis B. Global Health Action 2018; 11(1): 1433987 doi: 10.1080/16549716.2018.1433987
|
| 42 |
H. J. Tsai, Y. W. Chuang, S. W. Lee, C. Y. Wu, H. Z. Yeh, T. Y. Lee. Using the chronic kidney disease guidelines to evaluate the renal safety of tenofovir disoproxil fumarate in hepatitis B patients. Alimentary Pharmacology & Therapeutics 2018; 47(12): 1673 doi: 10.1111/apt.14682
|
| 43 |
Yu-Ting Zhang, Jing Liu, Xiao-Ben Pan, Yi-Dan Gao, Yin-Fei Hu, Li Lin, Hua-Jun Cheng, Gong-Ying Chen. Successful treatment of infantile hepatitis B with lamivudine: A case report. World Journal of Clinical Cases 2021; 9(14): 3442-3448 doi: 10.12998/wjcc.v9.i14.3442
|
| 44 |
Sanjit Boora, Vikrant Sharma, Sulochana Kaushik, Ajoy Varma Bhupatiraju, Sandeep Singh, Samander Kaushik. Hepatitis B virus-induced hepatocellular carcinoma: a persistent global problem. Brazilian Journal of Microbiology 2023; 54(2): 679 doi: 10.1007/s42770-023-00970-y
|
| 45 |
Idanna Innocenti, Francesca Morelli, Francesco Autore, Andrea Corbingi, Raffaella Pasquale, Federica Sorà, Maurizio Pompili, Luca Laurenti. HBV reactivation in CLL patients with occult HBV infection treated with ibrutinib without viral prophylaxis. Leukemia & Lymphoma 2019; 60(5): 1340 doi: 10.1080/10428194.2018.1523401
|
| 46 |
Si-Si Yang, Cheng-Wei Cai, Xue-Qing Ma, Jia Xu, Cheng-Bo Yu. Efficacy and cost-effectiveness of antiviral regimens for entecavir-resistant hepatitis B: A systematic review and network meta-analysis. Hepatobiliary & Pancreatic Diseases International 2020; 19(6): 507 doi: 10.1016/j.hbpd.2020.09.007
|
| 47 |
Keping Wu, Xiaochang Xu, Leidan Huang, Enyi Zhu, Yejing Dong, Zhijuan Zhang, Xiuhong Yan, Yimin Zhang. Telbivudine-induced rhabdomyolysis in a patient undergoing haemodialysis: A case report and review of literature. Journal of International Medical Research 2023; 51(12) doi: 10.1177/03000605231222244
|
| 48 |
Vitus Sambo Badii, Kwame Ohene Buabeng, Thomas Agyarko Poku, Arnold Donkor Forkuo, Bright Boafo Boamah, Stephen Mensah Arhin, Daniel Edem Kpewou. Tenofovir-Based Highly Active Antiretroviral Therapy Is Associated with Superior CD4 T Cells Repopulation Compared to Zidovudine-Based HAART in HIV 1 Infected Adults. International Journal of Chronic Diseases 2018; 2018: 1 doi: 10.1155/2018/3702740
|